• 3398 Citations
  • 32 h-Index
1979 …2019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Fabrizio Barbetti is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 15 Similar Profiles
Insulin Medicine & Life Sciences
Mutation Medicine & Life Sciences
Medical problems Chemical Compounds
Genes Medicine & Life Sciences
Insulin Resistance Medicine & Life Sciences
Insulin Receptor Medicine & Life Sciences
Glucose Medicine & Life Sciences
Glucokinase Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1979 2019

  • 3398 Citations
  • 32 h-Index
  • 104 Article
  • 3 Review article
  • 1 Conference contribution

Insulin: still a miracle after all these years

Barbetti, F. & Taylor, S. I., Jul 2 2019, In : Journal of Clinical Investigation. 130

Research output: Contribution to journalArticle

Insulin
Type 1 Diabetes Mellitus
Exome
C-Peptide
Genetic Testing

Can HbA1c combined with fasting plasma glucose help to assess priority for GCK-MODY vs HNF1A-MODY genetic testing?

Delvecchio, M., Salzano, G., Bonura, C., Cauvin, V., Cherubini, V., d'Annunzio, G., Franzese, A., Giglio, S., Grasso, V., Graziani, V., Iafusco, D., Iughetti, L., Lera, R., Maffeis, C., Maltoni, G., Mantovani, V., Menzaghi, C., Patera, P. I., Rabbone, I., Reindstadler, P. & 8 others, Scelfo, S., Tinto, N., Toni, S., Tumini, S., Lombardo, F., Nicolucci, A., Barbetti, F. & Pedi, D. S. G. I. S., Sep 1 2018, In : Acta Diabetologica. 55, 9, p. 981-983 3 p.

Research output: Contribution to journalArticle

Can HbA1c combined with fasting plasma glucose help to assess priority for GCK-MODY vs HNF1A-MODY genetic testing?

Diabetes Study Group of the Italian Society of Pediatric Endocrinology and Diabetes (ISPED), Sep 2018, In : Acta Diabetologica. 55, 9, p. 981-983 3 p.

Research output: Contribution to journalArticle

Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study

Neonatal Diabetes International Collaborative Group, Aug 2018, In : The Lancet Diabetes and Endocrinology. 6, 8, p. 637-646 10 p.

Research output: Contribution to journalArticle

Cohort Studies
Safety
Mutation
Therapeutics
Norway
4 Citations (Scopus)
Mutation
Subcutaneous Infusions
Genetic Counseling
Therapeutics
Type 2 Diabetes Mellitus